Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Eli Lilly and Company

LLY
32,46
1,08 (3,44%)
06 Feb 2025 - Chiuso
Dati in Tempo Reale
Borsa: NEO
Tipo: Ricevuta di Deposito
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
06/2/202522:04EDGAR2Form 144 - Report of proposed sale of securities
06/2/202517:30IHMARKETNEWSEli Lilly Stock Price Rises As Profits Exceed Expectations
06/2/202513:05EDGAR2Form 8-K - Current report
06/2/202512:45PRNUSLilly reports full Q4 2024 financial results and provides..
04/2/202522:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202521:54EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
23/1/202522:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202516:00PRNUSLilly confirms date and conference call for fourth-quarter..
15/1/202522:06PRNUSFDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's..
14/1/202515:05EDGAR2Form 8-K - Current report
14/1/202515:00PRNUSLilly provides update on 2024 revenue guidance, announces..
13/1/202515:00PRNUSLilly to acquire Scorpion Therapeutics' mutant-selective..
07/1/202516:00PRNUSLilly to participate in J.P. Morgan Healthcare Conference
20/12/202422:32PRNUSFDA approves Zepbound® (tirzepatide) as the first and only..
18/12/202402:00PRNUSLilly's Kisunla™ (donanemab-azbt) Approved in China for the..
17/12/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202412:00PRNUSLilly and EVA Pharma announce regulatory approval and..
13/12/202414:11PRNUSLilly's Omvoh® (mirikizumab) recommended by CHMP for..
11/12/202414:15PRNUSLilly's Imlunestrant, an Oral SERD, Significantly Improved..
09/12/202423:45PRNUSPhase 3 results for Lilly's Jaypirca® (pirtobrutinib) in..
09/12/202422:17PRNUSLilly announces new $15 billion share repurchase program and..
09/12/202415:00PRNUSCORE Kidney, Boehringer Ingelheim and Lilly Are Turning Up..
05/12/202421:30PRNUSLilly announces $3 billion expansion of its recently..
04/12/202422:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/12/202412:45PRNUSLilly's Zepbound® (tirzepatide) superior to Wegovy®..
20/11/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 31,15 Min: 31,12 Max: 32,98
Chiusura: 31,38

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network